413 related articles for article (PubMed ID: 2940080)
1. Metoprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in hypertension, ischaemic heart disease and related cardiovascular disorders.
Benfield P; Clissold SP; Brogden RN
Drugs; 1986 May; 31(5):376-429. PubMed ID: 2940080
[TBL] [Abstract][Full Text] [Related]
2. Comparison between the ECG Outcomes of Metoprolol and Bisoprolol.
Almeman AA; Alharbi YO; Alwahhabi AS; Almutairi AA; Alnasr MY; Almesnid A
Cardiovasc Hematol Agents Med Chem; 2023 Oct; ():. PubMed ID: 37909439
[TBL] [Abstract][Full Text] [Related]
3. Nose-to-Heart Approach: Unveiling an Alternative Route of Acute Treatment.
Papakyriakopoulou P; Valsami G; Kadoglou NPE
Biomedicines; 2024 Jan; 12(1):. PubMed ID: 38255302
[TBL] [Abstract][Full Text] [Related]
4. The pharmacokinetics and pharmacodynamics of metoprolol after conventional and controlled-release administration in combination with hydrochlorothiazide in healthy volunteers.
Lundborg P; Abrahamsson B; Wieselgren I; Walter M
Eur J Clin Pharmacol; 1993; 45(2):161-3. PubMed ID: 8223839
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic and pharmacodynamic properties of a new controlled-release formulation of metoprolol: a comparison with conventional tablets.
Sandberg A; Blomqvist I; Jonsson UE; Lundborg P
Eur J Clin Pharmacol; 1988; 33 Suppl():S9-14. PubMed ID: 3371395
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and pharmacodynamics of controlled-release metoprolol: a comparison with atenolol.
Blomqvist I; Westergren G; Sandberg A; Jonsson UE; Lundborg P
Eur J Clin Pharmacol; 1988; 33 Suppl():S19-24. PubMed ID: 3371390
[TBL] [Abstract][Full Text] [Related]
7. Clinical pharmacokinetics of metoprolol.
Regårdh CG; Johnsson G
Clin Pharmacokinet; 1980; 5(6):557-69. PubMed ID: 7002420
[No Abstract] [Full Text] [Related]
8. Mode of action of beta-adrenoceptor blocking agents in hypertension. A comparison between metoprolol and pindolol with special reference to peripheral vascular effects.
Svensson A; Gudbrandsson T; Sivertsson R; Hansson L
Acta Med Scand Suppl; 1982; 665():103-8. PubMed ID: 6760678
[TBL] [Abstract][Full Text] [Related]
9. Common conditions associated with hereditary haemochromatosis genetic variants: cohort study in UK Biobank.
Pilling LC; Tamosauskaite J; Jones G; Wood AR; Jones L; Kuo CL; Kuchel GA; Ferrucci L; Melzer D
BMJ; 2019 Jan; 364():k5222. PubMed ID: 30651232
[TBL] [Abstract][Full Text] [Related]
10. β-blockers: Their new life from hypertension to cancer and migraine.
Fumagalli C; Maurizi N; Marchionni N; Fornasari D
Pharmacol Res; 2020 Jan; 151():104587. PubMed ID: 31809852
[TBL] [Abstract][Full Text] [Related]
11. Metoprolol kinetics and dose response in hypertensive patients.
Myers MG; Thiessen JJ
Clin Pharmacol Ther; 1980 Jun; 27(6):756-62. PubMed ID: 7379442
[TBL] [Abstract][Full Text] [Related]
12. A comparison of 100 mg atenolol and 100 mg metoprolol once a day at rest and during exercise in hypertensives.
Nilsson OR; Atterhög JH; Castenfors J; Jorfelt L; Karlberg BE; Thulin T; Tolagen K; Wettre S; Ohman KP
Acta Med Scand; 1984; 216(3):301-7. PubMed ID: 6388253
[TBL] [Abstract][Full Text] [Related]
13. On the coexistence of beta 1- and beta 2-adrenoceptors in various organs.
Wagner J; Nick B; Rohm N; Schümann HJ
Arch Int Pharmacodyn Ther; 1981 Jan; 249(1):26-38. PubMed ID: 6261704
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular changes in anaesthetised rats after the intra-hypothalamic administration of adrenaline.
Borkowski KR; Finch L
Clin Exp Hypertens (1978); 1978; 1(2):279-91. PubMed ID: 755652
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
